SpringerLink
Log in

Therapeutische Optionen zur Behandlung des Delirs

Pharmocological management of delirium

  • Arzneimitteltherapie
  • Published:
DGNeurologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Hapca S, Guthrie B, Cvoro V, Bu F, Rutherford AC, Reynish E et al (2018) Mortality in people with dementia, delirium, and unspecified cognitive impairment in the general hospital: prospective cohort study of 6,724 patients with 2 years follow-up. Clin Epidemiol 10:1743–1753

    Article  Google Scholar 

  2. Inouye SK, Westendorp RGJ, Saczynski JS (2014) Delirium in elderly people. Lancet 383(9920):911–922

    Article  Google Scholar 

  3. Peritogiannis V, Bolosi M, Lixouriotis C, Rizos DV (2015) Recent insights on prevalence and corelations of hypoactive delirium. Behav Neurol 2015:416792

    Article  Google Scholar 

  4. van Meenen LCC, van Meenen DMP, de Rooij SE, ter Riet G (2014) Risk prediction models for postoperative delirium: a systematic review and meta-analysis. J Am Geriatr Soc 62(12):2383–2390

    Article  Google Scholar 

  5. Albensi BC (2019) Dysfunction of mitochondria: implications for Alzheimer’s disease. Int Rev Neurobiol 145:13–27

    Article  CAS  Google Scholar 

  6. Klaassens BL, van Gerven JMA, Klaassen ES, van der Grond J, Rombouts SARB (2018) Serotonergic and cholinergic modulation of functional brain connectivity: a comparison between young and older adults. Neuroimage 169:312–322

    Article  CAS  Google Scholar 

  7. Ramírez-Bermúdez J, Perez-Neri I, Montes S, Nente F, Ramirez-Abascal M, Carrillo-Mezo R et al (2020) Dopaminergic hyperactivity in neurological patients with delirium. Arch Med Res 50(8):477–483

    Article  Google Scholar 

  8. Wang Y, Shen X (2018) Postoperative delirium in the elderly: the potential neuropathogenesis. Aging Clin Exp Res 30(11):1287–1295

    Article  Google Scholar 

  9. Wallesch C‑W, Förstl H (2012) Demenzen: Referenzreihe Neurologie, 2. Aufl. Thieme, Stuttgart, S 316–330

    Google Scholar 

  10. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2015) S3 Analgesie Sedierung Delirmanagement Intensivmedizin. https://www.awmf.org/uploads/tx_szleitlinien/001-012l_S3_Analgesie_Sedierung_Delirmanagement_Intensivmedizin_2015-08_01.pdf. Zugegriffen: 10. Jan. 2019

  11. Silva-Jr JM, Katayama HT, Nogueira FAM, Moura TB, Alves TL, de Oliveira BW (2019) Comparison of dexmedetomidine and benzodiazepine for intraoperative sedation in elderly patients: a randomized clinical trial. Reg Anesth Pain Med 44(3):319–324

    Article  Google Scholar 

  12. Thom RP, Mock CK, Teslyar P (2017) Delirium in hospitalized patients: risks and benefits of antipsychotics. Cleve Clin J Med 84(8):616–622

    Article  Google Scholar 

  13. Cerveira CCT, Pupo CC, Dos Santos SDS, Santos JEM (2017) Delirium in the elderly: a systematic review of pharmacological and non-pharmacological treatments. Dement neuropsychol 11(3):270–275

    Article  Google Scholar 

  14. Reznik ME, Slooter AJC (2019) Delirium management in the ICU. Curr Treat Options Neurol 21(11):59

    Article  Google Scholar 

  15. Pieri M, De Simone A, Rose S, De Domenico P, Lembo R, Denaro G et al (2019) Trials focusing on prevention and treatment of delirium after cardiac surgery: a systematic review of randomized evidence. J Cardiothorac Vasc Anesth. https://doi.org/10.1053/j.jvca.2019.09.028

    Article  PubMed  Google Scholar 

  16. Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN et al (2018) Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med 379(26):2506–2516

    Article  CAS  Google Scholar 

  17. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2015) S1 Leitlinie Alkoholdelir und Verwirrtheitszustände. https://www.dgn.org/images/red_leitlinien/LL_2014/PDFs_Download/030006_LL_Alkoholdelir_und_Verwirrtheitszust%C3%A4nde_final.pdf. Zugegriffen: 10. Jan. 2019

Download references

Author information

Authors and Affiliations

  1. Bereich Demenzsensibles Krankenhaus, Klinik für Neurologie mit Institut für Translationale Neurologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Geb. A1, 48149, Münster, Deutschland

    T. Duning, S. Beheiri & K. Ilting-Reuke

Authors
  1. T. Duning
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Beheiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Ilting-Reuke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Duning.

Ethics declarations

Interessenkonflikt

T. Duning, S. Beheiri und K. Ilting-Reuke geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

F. Block, Schwerin

S.G. Meuth, Münster

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duning, T., Beheiri, S. & Ilting-Reuke, K. Therapeutische Optionen zur Behandlung des Delirs. DGNeurologie 3, 485–487 (2020). https://doi.org/10.1007/s42451-020-00183-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42451-020-00183-9

Search

Navigation